(Q36046585)

11 August 2017

1 reference

title

Frequent non-cardiac comorbidities in patients with chronic heart failure (English)

1 reference

11 August 2017

0 references

1 reference

chronic heart failure

1 reference

Ulf Dahlström

1

1 reference

11 August 2017

publication date

1 March 2005

1 reference

European Journal of Heart Failure

11 August 2017

published in

1 reference

11 August 2017

volume

7

1 reference

11 August 2017

issue

3

1 reference

11 August 2017

page(s)

309-316

1 reference

Heart failure in the 21st century: a cardiogeriatric syndrome

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Recognising the limits of randomized clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

The treatment of unrelated disorders in patients with chronic medical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Noncardiac comorbidity increases preventable hospitalizations and mortality among medicare beneficiaries with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

The epidemiology of heart failure: the Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

The progression from hypertension to congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Hypertension: an important precursor of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Congestive heart failure due to hypertensive ventricular diastolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Differentiating systolic from diastolic heart failure: pathophysiologic and therapeutic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Diabetes and cardiovascular disease. The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Glycemic control and heart failure among adult patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure. Muscle blood flow is reduced with maintenance of arterial perfusion pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Skeletal muscle metabolism in patients with congestive heart failure: relation to clinical severity and blood flow.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

New type of cardiomyopathy associated with diabetic glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

The diabetic heart: metabolic causes for the development of a cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Myocardial composition and function in diabetes. The effects of chronic insulin use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

How hyperglycemia promotes atherosclerosis: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Angiographic Findings and Outcome in Diabetic Patients Treated With Thrombolytic Therapy for Acute Myocardial Infarction: The GUSTO-I Experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Hypoglycaemia associated with use of inhibitors of angiotensin converting enzyme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Managed care and outcomes of hospitalization among elderly patients with congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Tolerability of carvedilol in patients with heart failure and concomitant chronic obstructive pulmonary disease or asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

The prevalence of anemia in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

The importance of anemia and its correction in the management of severe congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Prevalence of anemia in patients with chronic heart failure and their clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Effect of carvedilol on survival in severe chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Therapy with recombinant human erythropoietin reduces cardiac size and improves heart function in chronic hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Erythropoietin and systemic hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJHEART.2005.01.008

10.1016/J.EJHEART.2005.01.008

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference